TY - JOUR T1 - A randomized, open-label study to evaluate efficacy and safety of ombitasvir/paritaprevir/ritonavir co-administered with ribavirin in adults with genotype 4 chronic hepatitis C infection and cirrhosis. JF - Journal of Hepatology Y1 - 2015 A1 - Asselah, T. A1 - Hassanien, T. A1 - Qadish, R.B. A1 - et al. VL - 62 IS - S861 ER -